Activation of peripheral delta opioid receptors increases cardiac tolerance to arrhythmogenic effect of ischemia/reperfusion

Academic Emergency Medicine

Volumn 21, Issue 1, 2014, Pages 31-39

  Maslov, Leonid N ^a   Oeltgen, Peter R ^b   Lishmanov, Yury B ^a   Brown, Stephen A ^b,c   Barzakh, Eva I ^d   Krylatov, Andrey V ^a   Pei, Jian Ming ^e  

^a CARDIOLOGY RESEARCH INSTITUTE   (Russian Federation)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DELT DVARIANT; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN E; DELTORPHIN II; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; NOCICEPTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARRHYTHMOGENESIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HEMODYNAMIC PARAMETERS; LEFT CORONARY ARTERY; MALE; NONHUMAN; OPEN STUDY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANALGESICS, OPIOID; ANIMALS; ARRHYTHMIAS, CARDIAC; ENKEPHALINS; MALE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; OPIOID PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; REPERFUSION INJURY;

EID: 84891857770     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/acem.12286     Document Type: Article

References (39)

1. Stellbrink C,. What an emergency physician needs to know about acute care of cardiac arrhythmias. J. Emerg Trauma Shock. 2010; 3: 126-8.
2. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainamide, flecainamide, or placebo. The Cardiac Arrhythmias Suppression Trial. N Engl J Med. 1991; 324: 781-8.
3. UpToDate. Major Side Effects of Amioderone. Available at: http://www.uptodate.com/contents/major-side-effects-of-amioderone. Accessed Oct 20, 2013.
4. Fagbemi O, Kane KA, Lepran I,. Anti-arrhythmic actions of meptazinol, a partial agonist at opiate receptors, in acute myocardial ischemia. Br J Pharmacol. 1983; 78: 455-60. (Pubitemid 13162988)
5. Saini V, Carr DB, Verrier RL,. Comparative effects of the opioids fentanyl and buprenorphine on ventricular vulnerability during acute coronary artery occlusion. Cardiovasc Res. 1989; 23: 1001-6. (Pubitemid 20016621)
6. Hess L, Vrana M, Vranova Z, Fejfar Z,. The antifibrillatory effect of fentanyl, sufentanil and carfentanil in acute phase of local myocardial ischemia in the dog. Acta Cardiol. 1989; 44: 303-11. (Pubitemid 19229683)
7. Maslov LN, Lishmanov YB,. The anti-arrhythmic effect of D-Ala2, Leu5, Arg6-enkephalin and its possible mechanism. Int J Cardiol. 1993; 40: 89-94. (Pubitemid 23211231)
8. Polonskii VM, Yarygin KN, Krovosheev OG, Moskovkin GN, Vinogradov VA,. Effect of the antiulcerative action (central or peripheral) of the synthetic enkephalin analog dalargin in experimental cysteamine-induced duodenal ulcer in rats. Bull Exp Biol Med. 1987; 103: 488-90.
9. Fryer RM, Hsu AK, Nagase H, Gross GJ,. Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels. J Pharmacol Exp Ther. 2000; 294: 451-7. (Pubitemid 30490815)
10. ATP channels and the autonomic nervous system. Life Sci. 2009; 84: 657-63.
11. Maslov LN, Lishmanov YB, Oeltgen PR, et al. Comparative analysis of the cardioprotective properties of opioid receptor agonists in a rat model of myocardial infarction. Acad Emerg Med. 2010; 17: 1239-46.
12. Maslov LN, Lishmanov YB, Budankova EV, et al. Contribution of the endogenous opioid system to regulation of heart resistance to the arrhythmogenic effect of short-term ischemia and reperfusion. Biol Bull. 2005; 32: 375-80. (Pubitemid 41176109)
13. Kodani E, Xuan YT, Takanoh H, Tang XL, Bolli R,. Role of cyclic guanosine monophosphate in late preconditioning in conscious rabbits. Circulation. 2002; 105: 3046-52. (Pubitemid 34693840)
14. Russell DC, Lawrie JS, Riemersma RA, Oliver MF,. Mechanisms of phase 1a and 1b early ventricular arrhythmias during acute myocardial ischemia in the dog. Am J Cardiol. 1984; 53: 307-12. (Pubitemid 14215376)
15. Schultz JE, Hsu AK, Nagase H, Gross GJ,. TAN-67, a δ1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels. Am J Physiol. 1998; 274: H909-14.
16. Knapp RJ, Landsman R, Waite S, et al. Properties of TAN-67, a nonpeptidic δ-opioid receptor agonist, at cloned human δ- and μ-opioid receptors. Eur J Pharmacol. 1995; 291: 129-34.
17. Roques BP, Gacel G, Dauge V,. Novel approaches in the development of new analgesics. Neurophysiol Clin. 1990; 20: 369-87.
18. Schiller PW, Weltrowska G, Nguyen TM, Wilkes BC, Chung NN, Lemieux C,. TIPP[ψ]: a highly potent and stable pseudopeptide δ opioid receptor antagonist with extraordinary δ selectivity. J Med Chem. 1993; 36: 3182-7. (Pubitemid 23326274)
19. 2-opiate receptor agonists for prevention of the experimental adrenal arrhythmias. Bull Exp Med. 1997; 124: 873-5.
20. Beattie WS, Buckley DN, Forrest JB,. Epidural morphine reduces the risk postoperative myocardial ischaemia in patients with cardiac risk factors. Can J Anaesth. 1993; 40: 532-41. (Pubitemid 23280005)
21. Ling J, Wong GT, Yao L, Xia Z, Irwin MG,. Remote pharmacological post-conditioning by intrathecal morphine: cardiac protection from spinal opioid receptor activation. Acta Anaesthesiol Scand. 2010; 54: 1097-104.
22. Lu Y, Dong C, Yu J, Li L,. Role of central and peripheral opioid receptors in the cardioprotection of intravenous morphine preconditioning. Ir J Med Sci. 2011; 180: 881-5.
23. Bergey JL, Beil ME,. Antiarrhythmic evaluation of naloxone against acute coronary occlusion-induced arrhythmias in pigs. Eur J Pharmacol. 1983; 90: 427-31. (Pubitemid 13060869)
24. Zhan ZY, Lee AY, Wong TM,. Naloxone blocks the cardiac effects of myocardial ischaemia and reperfusion in the rat isolated heart. Clin Exp Pharmacol Physiol. 1985; 12: 373-8. (Pubitemid 16178961)
25. Sitsapesan R, Parratt JR,. The effects of drugs interacting with opioid receptors on the early ventricular arrhythmias arising from myocardial ischaemia. Br J Pharmacol. 1989; 97: 795-800. (Pubitemid 19168713)
26. Wong TM, Lee AY, Tai KK,. Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart-an attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis. J Mol Cell Cardiol. 1990; 22: 1167-75. (Pubitemid 20378829)
27. McIntosh M, Kane K, Parratt J,. Effects of selective opioid receptor agonists and antagonists during myocardial ischaemia. Eur. J Pharmacol. 1992; 210: 37-44.
28. Lee AY,. Stereospecific antiarrhythmic effects of naloxone against myocardial ischaemia and reperfusion in the dog. Br J Pharmacol. 1992; 107: 1057-60.
29. Murphy DB, Murphy MB,. Opioid antagonist modulation of ischaemia-induced ventricular arrhythmias: a peripheral mechanism. J Cardiovasc Pharmacol. 1999; 33: 122-5. (Pubitemid 29013710)
30. Sander GE, Lowe RF, Giles TD,. The effects of barbiturates upon the hemodynamic responses to intravenous methionine-enkephalin in dogs: modulation by the GABA complex. Peptides. 1986; 7: 259-65. (Pubitemid 16059307)
31. 2-specific opioid receptor agonist and hibernating woodchuck plasma fraction provide ischemic neuroprotection. Acad Emerg Med. 2008; 15: 250-7.
32. Loscal J, Welch G,. Nitric oxide and its role in cardiovascular system. Prog Cardiovasc Dis. 1995; 38: 87-104.
33. Ignarro LJ, Buga GM, Wei LH, Bauer PM, Wu G, del Soldato P,. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle proliferation. Proc Natl Acad Sci U S A. 2001; 98: 4202-8. (Pubitemid 32249922)
34. Lefer AM, Lefer DJ,. The role of nitric oxide and cell adhesion molecules on the microcirculation during ischemia-reperfusion. Cardio Res. 1996; 32: 743-51. (Pubitemid 26332313)
35. Sugiyama S, Okada Y, Sukhova GK, Vimani R, Heinecke JW, Libby P,. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol. 2001; 158: 879-91. (Pubitemid 32221781)
36. Holvoet P,. Oxidative modification of low-density lipoproteins in atherothrombosis. Acta Cardiol. 1998; 53: 253-60. (Pubitemid 29070682)
37. Jones SP, Girod WG, Palazzo AJ,. Myocardial ischemia-reperfusion injury is exacerbated in the absence of endothelial cell nitric oxide synthase. Am J Physiol. 1999; 276: H1567-73. (Pubitemid 29246543)
38. Oeltgen PR, Govindaswami M, Witzke DB,. 24-Hour pretreatment with δ opioid enhances survival from hemorrhagic shock. Acad Emerg Med. 2006; 13: 127-33. (Pubitemid 43155817)
39. 2-opioid receptor agonist, increases recovery and survival after severe hemorrhagic shock in behaving rats. Shock. 2008; 29 (1): 42-8.